相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。SARS-CoV-2 antibody response after COVID-19 in patients with rheumatic disease
Kristin M. D'Silva et al.
ANNALS OF THE RHEUMATIC DISEASES (2021)
A Cluster-Randomized Trial of Hydroxychloroquine for Prevention of Covid-19
Oriol Mitja et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry
Anja Strangfeld et al.
ANNALS OF THE RHEUMATIC DISEASES (2021)
Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection
Jianmin Zuo et al.
NATURE IMMUNOLOGY (2021)
Longitudinal Serological Analysis and Neutralizing Antibody Levels in Coronavirus Disease 2019 Convalescent Patients
Frauke Muecksch et al.
JOURNAL OF INFECTIOUS DISEASES (2021)
Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry
Milena Gianfrancesco et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Profile of Immunoglobulin G and IgM Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
Jiuxin Qu et al.
CLINICAL INFECTIOUS DISEASES (2020)
Detection of SARS-CoV-2-Specific Humoral and Cellular Immunity in COVID-19 Convalescent Individuals
Ling Ni et al.
IMMUNITY (2020)
Performance Characteristics of the Abbott Architect SARS-CoV-2 IgG Assay and Seroprevalence in Boise, Idaho
Andrew Bryan et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2020)
TH17 responses in cytokine storm of COVID-19: An emerging target of JAK2 inhibitor Fedratinib
Dandan Wu et al.
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2020)
COVID-19 And Racial/Ethnic Disparities In Health Risk, Employment, And Household Composition
Thomas M. Selden et al.
HEALTH AFFAIRS (2020)
Leveraging the United States Epicenter to Provide Insights on COVID-19 in Patients With Systemic Lupus Erythematosus
Ruth Fernandez-Ruiz et al.
ARTHRITIS & RHEUMATOLOGY (2020)
COVID-19 in Patients With Inflammatory Arthritis: A Prospective Study on the Effects of Comorbidities and Disease-Modifying Antirheumatic Drugs on Clinical Outcomes
Rebecca H. Haberman et al.
ARTHRITIS & RHEUMATOLOGY (2020)
Performance Characteristics of Four High-Throughput Immunoassays for Detection of IgG Antibodies against SARS-CoV-2
Elitza S. Theel et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2020)
Rapid Decay of Anti-SARS-CoV-2 Antibodies in Persons with Mild Covid-19
F. Javier Ibarrondo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates
Edward E. Walsh et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient blood
Dianna L. Ng et al.
NATURE COMMUNICATIONS (2020)
Evaluating the Association of Clinical Characteristics With Neutralizing Antibody Levels in Patients Who Have Recovered From Mild COVID-19 in Shanghai, China
Fan Wu et al.
JAMA INTERNAL MEDICINE (2020)
Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans
Jeffrey Seow et al.
NATURE MICROBIOLOGY (2020)
Disproportionate Incidence of COVID-19 Infection, Hospitalizations, and Deaths Among Persons Identifying as Hispanic or Latino - Denver, Colorado March-October 2020
Laura Jean Podewils et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)
Assessment of Racial/Ethnic Disparities in Hospitalization and Mortality in Patients With COVID-19 in New York City
Gbenga Ogedegbe et al.
JAMA NETWORK OPEN (2020)
Robust neutralizing antibodies to SARS-CoV-2 infection persist for months
Ania Wajnberg et al.
SCIENCE (2020)
Repeated cross-sectional sero-monitoring of SARS-CoV-2 in New York City
Daniel Stadlbauer et al.
NATURE (2020)
Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine
Alexis Mathian et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Effect of Methotrexate, Anti-Tumor Necrosis Factor α, and Rituximab on the Immune Response to Influenza and Pneumococcal Vaccines in Patients With Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
Charlotte Hua et al.
ARTHRITIS CARE & RESEARCH (2014)
Infection risk in systemic lupus erythematosus patients: susceptibility factors and preventive strategies
A. Danza et al.
LUPUS (2013)
The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus:: A randomized trial
JP Buyon et al.
ANNALS OF INTERNAL MEDICINE (2005)
分享论文
